Medical Inventi S.A.

Follow us
Medical Inventi S.A.

Medical Inventi Improving Lives

About us

About FlexiOss®

The world’s first flexible bone substitute biomaterial that integrates naturally into the patient’s bone.

The product stimulates bone reconstruction and growth, eliminating the need for a second operation to remove the implant, and significantly reducing patients’ pain and discomfort.

Read more

Areas of application

Orthopaedics and traumatology

Filling of bone defects in the limbs caused by trauma (e.g. fractures) and after removal of cancerous lesions or inflammatory […]

Read more

Dentistry

Treatment of bone defects in the oral cavity post e.g. tooth extraction, apex of the dental root resection, treatment of […]

Read more

Veterinary medicine

Filling bone defects resulting from trauma, surgical procedures or conditions such as osteomyelitis, hip dysplasia or bone tumours.

Read more

Breakthrough in regenerative medicine

Medical Inventi researches, creates, develops and commercialises innovative medical product solutions focusing on improving patients’ quality of life.

We are the exclusive owner of the know-how, technology and patents relating to FlexiOss®.

Get to know us better
Polski Produkt Przyszłości
Klaster Lubelska Medycyna
Klaster LifeScience Kraków

26.07.2024

Achievements

Patent in India for FlexiOss® manufacturing technology

In recent days, the Indian Patent Office has granted us a patent for the invention ‘A MACHINE FOR MOULDING COMPOSITE […]

Read more

11.07.2024

Events

Meditech 2024 trade fair in Bogotá

Where are we going this time? At the Meditech 2024 trade fair in the Colombian capital, Bogotá. Meditech is a […]

Read more

10.07.2024

Events

Medlab Asia 2024 in Bangkok

From 10-12 July 2024, we participated in Medlab Asia 2024 in Bangkok! After the Polish MedTech seminar at the Bangkok […]

Read more

For investors

Investor relations aim to create and maintain effective communication between the Company and the investor community. The most important information for current and potential investors can be found here:

keyboard_arrow_up
Skip to content